Moderna Stock Impressive Rise At Session Start On Monday, Outperforms Market
Moderna set to file for us, EU clearance for its coronavirus vaccine. According to today’s article on ForexLive, “Moderna reaffirms that its vaccine is 94.1% effective in primary analysis – Vaccine was 94.1% effective in analysis of Phase 3 study, after 196 virus cases – Vaccine was 100% effective against strict virus cases in trial…